318 results
8-K/A
ABBV
Abbvie Inc
8 May 24
Departure of Directors or Certain Officers
5:00pm
A. Gonzalez
Susan E. Quaggin
Rebecca B. Roberts
Glenn F. Tilton
The stockholders ratified the appointment of Ernst & Young LLP as AbbVie’s independent
DEFA14A
ABBV
Abbvie Inc
18 Mar 24
Additional proxy soliciting materials
4:17pm
as AbbVie’s independent registered public accounting firm for 2024 For 3. Say on Pay – An advisory vote on the approval of executive compensation For 4
8-K
EX-1.1
qwsier2tzyg5wyp
26 Feb 24
Other Events
5:08pm
424B5
u3hh l5m53ior7
26 Feb 24
Prospectus supplement for primary offering
6:12am
S-8
EX-4.5
o9v7p p8cc
22 Feb 24
Registration of securities for employees
5:50pm
S-8
EX-23.2
wj2itmwdp9219nx
22 Feb 24
Registration of securities for employees
5:50pm
S-8
b83lrc k00ytra8
22 Feb 24
Registration of securities for employees
5:50pm
424B5
x6d4cnp83l1pkli
21 Feb 24
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
0kdw2mekcfqd8vmxmuvu
20 Feb 24
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
9:00am
8-K
EX-99.1
5244l9ghl7bgw7x8zqf
2 Feb 24
AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
7:51am
8-K
qevfk
12 Oct 23
Departure of Directors or Certain Officers
5:17pm
11-K
EX-23.1
nb9n0yq
28 Jun 23
Annual report of employee stock purchases
5:00pm